These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 38124403)
1. Disruption of LPA-LPAR1 pathway results in lung tumor growth inhibition by downregulating B7-H3 expression in fibroblasts. Meng F; Yin Z; Lu F; Wang W; Zhang H Thorac Cancer; 2024 Feb; 15(4):316-326. PubMed ID: 38124403 [TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway. Zhou T; Du L; Chen C; Han C; Li X; Qin A; Zhao C; Zhang K; Zhao J Cell Physiol Biochem; 2018; 45(4):1472-1486. PubMed ID: 29466791 [TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid-induced ADAM12 expression mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth. Do EK; Kim YM; Heo SC; Kwon YW; Shin SH; Suh DS; Kim KH; Yoon MS; Kim JH Int J Biochem Cell Biol; 2012 Nov; 44(11):2069-76. PubMed ID: 22903068 [TBL] [Abstract][Full Text] [Related]
4. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study. Yu X; Zhang Y; Chen H BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800 [TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts. Radhakrishnan R; Ha JH; Jayaraman M; Liu J; Moxley KM; Isidoro C; Sood AK; Song YS; Dhanasekaran DN Cancer Lett; 2019 Feb; 442():464-474. PubMed ID: 30503552 [TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway. Kim D; Kim HJ; Baek JO; Roh JY; Jun HS Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639115 [TBL] [Abstract][Full Text] [Related]
7. Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis. Takagi S; Sasaki Y; Koike S; Takemoto A; Seto Y; Haraguchi M; Ukaji T; Kawaguchi T; Sugawara M; Saito M; Funauchi Y; Ae K; Matsumoto S; Fujita N; Katayama R Oncogene; 2021 Sep; 40(36):5548-5558. PubMed ID: 34302117 [TBL] [Abstract][Full Text] [Related]
8. Glucagon-like Peptide-1 Secretion Is Inhibited by Lysophosphatidic Acid. Fernandes MF; Tomczewski MV; Duncan RE Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456981 [TBL] [Abstract][Full Text] [Related]
9. Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade. Miyabe Y; Miyabe C; Iwai Y; Yokoyama W; Sekine C; Sugimoto K; Harigai M; Miyasaka M; Miyasaka N; Nanki T Arthritis Res Ther; 2014 Oct; 16(5):461. PubMed ID: 25273676 [TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma. Sokolov E; Eheim AL; Ahrens WA; Walling TL; Swet JH; McMillan MT; Simo KA; Thompson KJ; Sindram D; McKillop IH J Surg Res; 2013 Mar; 180(1):104-13. PubMed ID: 23182454 [TBL] [Abstract][Full Text] [Related]
11. Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3. Shin SH; Kim J; Heo SC; Kwon YW; Kim YM; Kim IS; Lee TG; Kim JH Mol Cell Proteomics; 2012 Feb; 11(2):M111.012385. PubMed ID: 22159598 [TBL] [Abstract][Full Text] [Related]
12. Blockade of lysophosphatidic acid receptors LPAR1/3 ameliorates lung fibrosis induced by irradiation. Gan L; Xue JX; Li X; Liu DS; Ge Y; Ni PY; Deng L; Lu Y; Jiang W Biochem Biophys Res Commun; 2011 May; 409(1):7-13. PubMed ID: 21545790 [TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid enhances human umbilical cord mesenchymal stem cell viability without differentiation via LPA receptor mediating manner. Li N; Yan YL; Fu S; Li RJ; Zhao PF; Xu XY; Yang JP; Damirin A Apoptosis; 2017 Oct; 22(10):1296-1309. PubMed ID: 28766061 [TBL] [Abstract][Full Text] [Related]
14. Expression of the type 1 lysophosphatidic acid receptor in osteoblastic cell lineage controls both bone mineralization and osteocyte specification. Alioli CA; Demesmay L; Laurencin-Dalacieux S; Beton N; Farlay D; Follet H; Saber A; Duboeuf F; Chun J; Rivera R; Bouvard D; Machuca-Gayet I; Salles JP; Gennero I; Peyruchaud O Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158715. PubMed ID: 32330664 [TBL] [Abstract][Full Text] [Related]
15. Cyclic phosphatidic acid and lysophosphatidic acid induce hyaluronic acid synthesis via CREB transcription factor regulation in human skin fibroblasts. Maeda-Sano K; Gotoh M; Morohoshi T; Someya T; Murofushi H; Murakami-Murofushi K Biochim Biophys Acta; 2014 Sep; 1841(9):1256-63. PubMed ID: 24845645 [TBL] [Abstract][Full Text] [Related]
16. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer. Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202 [TBL] [Abstract][Full Text] [Related]
17. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer. Fan X; Huang J; Hu B; Zhou J; Chen L J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607 [TBL] [Abstract][Full Text] [Related]
18. The role of B7-H3 in tumors and its potential in clinical application. Feng R; Chen Y; Liu Y; Zhou Q; Zhang W Int Immunopharmacol; 2021 Dec; 101(Pt B):108153. PubMed ID: 34678689 [TBL] [Abstract][Full Text] [Related]
19. LPA signaling is regulated through the primary cilium: a novel target in glioblastoma. Loskutov YV; Griffin CL; Marinak KM; Bobko A; Margaryan NV; Geldenhuys WJ; Sarkaria JN; Pugacheva EN Oncogene; 2018 Mar; 37(11):1457-1471. PubMed ID: 29321663 [TBL] [Abstract][Full Text] [Related]
20. Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells. Zuckerman V; Sokolov E; Swet JH; Ahrens WA; Showlater V; Iannitti DA; Mckillop IH Oncotarget; 2016 Jan; 7(3):2951-67. PubMed ID: 26701886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]